Inventor · disambiguated record
Gerhard Niederfellner
Also filed as: NIEDERFELLNER GERHARD
14 granted patents·13 pending applications·49 citations·filing 2010–2020
90Inventor score
Top patents by PatentIndex Score
27 records- 0191US9388222B2Modified Pseudomonas exotoxin AUS HEALTH·Filed 2014·Granted Jul 12, 2016·15 cites·42 claims
- 0289US11732052B2Bispecific antibody molecules with antigen-transfected T-cells and their use in medicineHOFFMANN LA ROCHE·Filed 2020·Granted Aug 22, 2023·3 cites·19 claims
- 0385US9346886B2Humanized anti-CDCP1 antibodiesROCHE GLYCART AG·Filed 2012·Granted May 24, 2016·8 cites·2 claims
- 0482US9725512B2HER3 antibodies binding to the beta-hairpin of HER3HOFFMANN LA ROCHE·Filed 2013·Granted Aug 8, 2017·5 cites·8 claims
- 0580US10633451B2Bispecific antibody molecules with antigen-transfected T-cells and their use in medicineHOFFMANN LA ROCHE·Filed 2013·Granted Apr 28, 2020·4 cites·16 claims
- 0680US8883159B2Antibodies against CDCP1 for the treatment of cancerBOSSENMAIER BIRGIT·Filed 2010·Granted Nov 11, 2014·4 cites·10 claims
- 0780US8394928B2Humanized anti-CDCP1 antibodiesAUER JOHANNES·Filed 2010·Granted Mar 12, 2013·7 cites·33 claims
- 0871US9725511B2Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4HOFFMANN LA ROCHE·Filed 2013·Granted Aug 8, 2017·1 cites·17 claims
- 0968US9840565B2HER1 antigen binding proteins binding to the beta-hairpin of HER1HOFFMANN LA ROCHE·Filed 2015·Granted Dec 12, 2017·1 cites·14 claims
- 1065US2020181280A1Modified pseudomonas exotoxin aTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2019·Application pending·0 cites
- 1164US11618790B2Polypeptide-polynucleotide-complex and its use in targeted effector moiety deliveryHOFFMANN LA ROCHE·Filed 2019·Granted Apr 4, 2023·0 cites·11 claims
- 1264US9783611B2Anti-HER3 antibodies binding to the beta-hairpin of HER3HOFFMANN LA ROCHE·Filed 2015·Granted Oct 10, 2017·1 cites·9 claims
- 1362US10626177B2HER3 antigen binding proteins binding to the beta-hairpin of HER3HOFFMANN LA ROCHE·Filed 2017·Granted Apr 21, 2020·0 cites·13 claims
- 1462US2013156772A1Bispecific Anti ErbB1 / Anti cMet AntibodiesROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 1562US2013273054A1Bispecific Anti ErbB2/Anti cMet AntibodiesROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 1655US2014135482A1Bispecific Anti ErbB3 / Anti cMet AntibodiesROCHE GLYCART AG·Filed 2014·Application pending·0 cites
- 1754US10364290B2Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4HOFFMANN LA ROCHE·Filed 2017·Granted Jul 30, 2019·0 cites·16 claims
- 1854US2010254988A1Bispecific Anti ErbB2 / Anti cMet AntibodiesBOSSENMAIER BIRGIT·Filed 2010·Application pending·0 cites
- 1954US2017051072A1Modified pseudomonas exotoxin aUS HEALTH·Filed 2016·Application pending·0 cites
- 2054US2010254989A1Bispecific Anti ErbB1 / Anti c Met AntibodiesBOSSENMAIER BIRGIT·Filed 2010·Application pending·0 cites
- 2150US2013344094A1Polypeptide-polynucleotide-complex and its use in targeted effector moiety deliveryHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2249US2015232560A1Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2347US2018100022A1Her1 antigen binding proteins binding to the beta-hairpin of her1HOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2444US2010256339A1Bispecific Anti ErbB3 / Anti cMet AntibodiesBOSSENMAIER BIRGIT·Filed 2010·Application pending·0 cites
- 2540US2017096485A1Bispecific t cell activating antigen binding moleculesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2639US11547748B2Adoptive t-cell therapyHOFFMANN LA ROCHE·Filed 2017·Granted Jan 10, 2023·0 cites·24 claims
- 2731US2013336972A1Recombinant fc-fusion protein of the fifth fibronectin type iii domain of dccKLEIN CHRISTIAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gerhard Niederfellner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →